Scalp cooling during chemotherapy can be pivotal for AYA identity preservation and psychosocial functioning, facilitating ...

Cancer is a major thief. The disease can take your hair, your fingernails, your energy, your appetite. The list goes on and ...

Regulatory alignment from the FDA and MD Anderson IRB supports resumption of enrollment in a U.S./European proof-of-concept ...

FDA approved a PD-L1 companion test to identify patients with ovarian, fallopian tube or primary peritoneal cancer who may receive first-line Keytruda.

Minimal residual disease, or MRD, testing may have the potential to offer peace of mind to survivors of breast cancer, as a survivor and a care provider explained in interviews with CURE. CURE ...

In an interview, liver cancer survivor Charles Walker shared how family support and a living donor transplant changed his treatment journey and outlook.

Curtis Pesmen | Authors | CURE connects oncology patients, survivors, and caregivers with expert guidance, cancer updates, treatment education, and clinical trial access.

The U.S. Food and Drug Administration (FDA) recently approved the use of Darzalex Faspro (daratumumab and hyaluronidase-fihj) ...

During an interview with CURE, Chris Draft, founder of Team Draft, discussed how patients with cancer can begin to feel more in control and even step into advocacy after receiving ...

Prolonged diagnostic latency can follow vague fatigue, back pain, and breathing issues, reinforcing the need for persistent ...

Hope is positioned as an organizing principle for coping with post-treatment emotional distress, including isolation, ...

For many patients, the path to a liver cancer diagnosis is not straightforward. Symptoms can be vague, tests inconclusive and ...